Cargando…
TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer
Autores principales: | Li, Zequn, Cao, Shougen, Sun, Yuqi, Niu, Zhaojian, Liu, Xiaodong, Niu, Jun, Zhou, Yanbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361694/ https://www.ncbi.nlm.nih.gov/pubmed/35941647 http://dx.doi.org/10.1186/s12943-022-01626-5 |
Ejemplares similares
-
A novel prognostic factor TIPE2 inhibits cell proliferation and promotes apoptosis in pancreatic ductal adenocarcinoma (PDAC)
por: Sun, Yuqi, et al.
Publicado: (2021) -
TIPE2 acts as a biomarker for GIST risk category and suppresses the viability and invasiveness of GIST cells
por: Li, Zequn, et al.
Publicado: (2018) -
Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer
por: Li, Zequn, et al.
Publicado: (2021) -
TIPE2 acts as a biomarker for tumor aggressiveness and suppresses cell invasiveness in papillary thyroid cancer (PTC)
por: Jia, Wenyu, et al.
Publicado: (2018) -
Concordance Between Watson for Oncology and a Multidisciplinary Clinical Decision-Making Team for Gastric Cancer and the Prognostic Implications: Retrospective Study
por: Tian, Yulong, et al.
Publicado: (2020)